Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,229 | -185,211 | -126,150 | -83,799 | -34,536 |
| Depreciation Amortization | -800 | -19 | 702 | 585 | 321 |
| Accounts payable and accrued liabilities | -4,817 | 9,987 | -1,660 | -4,678 | -7,562 |
| Other Working Capital | 10,537 | -4,717 | -7,419 | -1,981 | -8,683 |
| Other Operating Activity | 16,716 | 16,189 | 19,990 | 16,452 | 12,948 |
| Operating Cash Flow | $-50,593 | $-163,771 | $-114,537 | $-73,421 | $-37,512 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -233 | -236 | -440 | -211 | -116 |
| Purchase Of Investment | N/A | -231,040 | -165,469 | -96,498 | -48,897 |
| Sale Of Investment | 39,505 | 180,999 | 117,499 | 44,915 | 14,865 |
| Investing Cash Flow | $39,272 | $-50,277 | $-48,410 | $-51,794 | $-34,148 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 100,000 | 50,000 | N/A | N/A |
| Common Stock Issued | 2,589 | 332,803 | 7,123 | 4,881 | 2,080 |
| Other Financing Activity | 0 | -3,898 | -2,523 | 0 | 0 |
| Financing Cash Flow | $2,589 | $428,905 | $54,600 | $4,881 | $2,080 |
| Beginning Cash Position | 476,304 | 261,447 | 261,447 | 261,447 | 261,447 |
| End Cash Position | 467,572 | 476,304 | 153,100 | 141,113 | 191,867 |
| Net Cash Flow | $-8,732 | $214,857 | $-108,347 | $-120,334 | $-69,580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,593 | -163,771 | -114,537 | -73,421 | -37,512 |
| Capital Expenditure | -233 | -736 | -440 | -211 | -116 |
| Free Cash Flow | -50,826 | -164,507 | -114,977 | -73,632 | -37,628 |